Seah H. Lim - Oct 4, 2022 Form 3/A Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Seah H. Lim
Stock symbol
EMMA
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
3/A
Date filed
12/20/2023, 10:33 AM
Date Of Original Report
Oct 6, 2022
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMMA Common stock, $0.001 par value 38.5K Oct 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EMMA Promissory Note due 9/16/2025 Oct 4, 2022 Common Stock 240K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock beneficially owned directly by the Reporting Person, which was erroneously not reported on a Form 3 filed on October 6, 2022.
F2 The shares shown are issuable upon maturity of the promissory note or earlier prepayment of the note.